P967: A MACHINE LEARNING MODEL FOR RISK PREDICTION IN MULTIPLE MYELOMA PROGRESSING AFTER THE FIRST LINE OF THERAPY

por Mosquera-Orgueira, Adrian, Perez, Marta Sonia Gonzalez, Diaz Arias, Jose Angel, Mateos, Maria-Victoria
Publicado 2023

P1234: A PROGNOSTIC MODEL BASED ON GENE EXPRESSION PARAMETERS PREDICTS A BETTER RESPONSE TO BORTEZOMIB-CONTAINING IMMUNOCHEMOTHERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA

por Mosquera-Orgueira, Adrian, Arias, Jose Angel Diaz, Serrano Martin, Rocio, Portela Piñeiro, Victor, Cid Lopez, Miguel, Peleteiro Raindo, Andres, Bao Perez, Laura, Perez, Marta Sonia Gonzalez, Encinas, Manuel Mateo Perez, Rodriguez, Maximo Francisco Fraga, Llamas, Juan Carlos Vallejo, Bello Lopez, Jose Luis
Publicado 2023

P878: SELINEXOR IN COMBINATION WITH DARATUMUMAB-BORTEZOMIB AND DEXAMETHASONE FOR THE TREATMENT OF RELAPSE OR REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS OF THE PHASE 2, MULTICENTE...

por Gonzalez-Calle, Veronica, Rodríguez-Otero, Paula, Sureda, Anna, de la Fuente, Felipe de Arriba, Reinoso Segura, Marta, Ribas, Paz, Pilar Gonzalez, Ana, Gonzalez Montes, Yolanda, Oriol, Albert, Martinez-Lopez, Joaquín, Perez, Marta Sonia Gonzalez, Garcia, Miguel Teodoro Hernandez, Sirvent Auzmendi, Maialen, Blade, Joan, Palacios, Juan José Lahuerta, San Miguel, Jesús, Mateos, Maria-Victoria
Publicado 2023